These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23706359)
1. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. Kersbergen KJ; de Vries LS; van Kooij BJ; Išgum I; Rademaker KJ; van Bel F; Hüppi PS; Dubois J; Groenendaal F; Benders MJ J Pediatr; 2013 Sep; 163(3):666-71.e1. PubMed ID: 23706359 [TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants. Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857 [TBL] [Abstract][Full Text] [Related]
3. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA; Harrison M; Clark RH Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192 [TBL] [Abstract][Full Text] [Related]
4. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Lodygensky GA; Rademaker K; Zimine S; Gex-Fabry M; Lieftink AF; Lazeyras F; Groenendaal F; de Vries LS; Huppi PS Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023 [TBL] [Abstract][Full Text] [Related]
5. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children. Rademaker KJ; Uiterwaal CS; Groenendaal F; Venema MM; van Bel F; Beek FJ; van Haastert IC; Grobbee DE; de Vries LS J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109 [TBL] [Abstract][Full Text] [Related]
7. Trial of early neonatal hydrocortisone: two-year follow-up. Peltoniemi OM; Lano A; Puosi R; Yliherva A; Bonsante F; Kari MA; Hallman M; Neonatology; 2009; 95(3):240-7. PubMed ID: 18931525 [TBL] [Abstract][Full Text] [Related]
8. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Warmerdam LA; van Wezel-Meijler G; de Vries LS; Groenendaal F; Steggerda SJ Neonatology; 2023; 120(5):615-623. PubMed ID: 37379806 [TBL] [Abstract][Full Text] [Related]
9. Bronchopulmonary Dysplasia Is Associated with Altered Brain Volumes and White Matter Microstructure in Preterm Infants. Lee JM; Choi YH; Hong J; Kim NY; Kim EB; Lim JS; Kim JD; Park HK; Lee HJ Neonatology; 2019; 116(2):163-170. PubMed ID: 31112968 [TBL] [Abstract][Full Text] [Related]
10. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial. He Y; Zhang Y; Gao S; Wang X; He N; Zhang D; Dong W; Wieg C; Lei X Trials; 2020 Sep; 21(1):762. PubMed ID: 32883333 [TBL] [Abstract][Full Text] [Related]
11. Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia. Nesterenko TH; Nolan B; Hammad TA; Aly H Am J Perinatol; 2008 Apr; 25(4):251-4. PubMed ID: 18548401 [TBL] [Abstract][Full Text] [Related]
12. Uncomplicated intraventricular hemorrhage is followed by reduced cortical volume at near-term age. Vasileiadis GT; Gelman N; Han VK; Williams LA; Mann R; Bureau Y; Thompson RT Pediatrics; 2004 Sep; 114(3):e367-72. PubMed ID: 15342899 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. Peltoniemi O; Kari MA; Heinonen K; Saarela T; Nikolajev K; Andersson S; Voutilainen R; Hallman M J Pediatr; 2005 May; 146(5):632-7. PubMed ID: 15870666 [TBL] [Abstract][Full Text] [Related]
15. Postnatal steroids in extremely low birth weight infants: betamethasone or hydrocortisone? Ben Said M; Hays S; Loys CM; Coletto L; Godbert I; Picaud JC Acta Paediatr; 2013 Jul; 102(7):689-94. PubMed ID: 23551291 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Morris IP; Goel N; Chakraborty M Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162 [TBL] [Abstract][Full Text] [Related]
17. [Glucocorticoide therapy in premature infants: French practices in 2006]. Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441 [TBL] [Abstract][Full Text] [Related]
18. Perinatal risk factors altering regional brain structure in the preterm infant. Thompson DK; Warfield SK; Carlin JB; Pavlovic M; Wang HX; Bear M; Kean MJ; Doyle LW; Egan GF; Inder TE Brain; 2007 Mar; 130(Pt 3):667-77. PubMed ID: 17008333 [TBL] [Abstract][Full Text] [Related]
19. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations]. Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322 [TBL] [Abstract][Full Text] [Related]
20. Bronchopulmonary dysplasia is associated with delayed structural brain maturation in preterm infants. Neubauer V; Junker D; Griesmaier E; Schocke M; Kiechl-Kohlendorfer U Neonatology; 2015; 107(3):179-84. PubMed ID: 25632975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]